Description Of Business Segments (Tables)

6 Months Ended

Jun. 30, 2023

Information Concerning Consolidated Operations by Business Segment

Information concerning consolidated operations by business segment is presented in the following tables:


	Three Months Ended June 30						Six Months Ended June 30
	2023		2022		Change		2023		2022		Change
NET SALES
Personal Care	$	2,685	$	2,710	-1	%	$	5,389	$	5,439	-1	%
Consumer Tissue	1,549		1,537		+1	%	3,183		3,105		+3	%
K-C Professional	887		802		+11	%	1,734		1,582		+10	%
Corporate & Other	13		14		N.M.		23		32		N.M.
TOTAL NET SALES	$	5,134	$	5,063	+1	%	$	10,329	$	10,158	+2	%

OPERATING PROFIT
Personal Care	$	472	$	466	+1	%	$	959	$	941	+2	%
Consumer Tissue	200		178		+12	%	440		349		+26	%
K-C Professional	187		85		+120	%	346		175		+98	%
Corporate & Other(a)	(801)		(106)		N.M.		(885)		(208)		N.M.
Other (income) and expense, net(a)	(55)		2		N.M.		(40)		(57)		-30	%
TOTAL OPERATING PROFIT	$	113	$	621	-82	%	$	900	$	1,314	-32	%

(a) Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.

N.M. - Not Meaningful

^[1]

Sales of Principal Products

Sales of Principal Products:


	Three Months Ended June 30				Six Months Ended June 30
(Billions of dollars)	2023		2022		2023		2022
Baby and child care products	$	1.8	$	1.9	$	3.5	$	3.7
Consumer tissue products	1.5		1.5		3.2		3.1
Away-from-home professional products	0.9		0.8		1.7		1.6
All other	0.9		0.9		1.9		1.8
Consolidated	$	5.1	$	5.1	$	10.3	$	10.2

[1]

Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including in 2023 the net benefit related to the sale of our Brazil tissue and K-C Professional business and the impairment of intangible assets, and in 2022 the non-cash, non-recurring gain and transaction and integration costs related to the acquisition of a controlling interest in Thinx.N.M. - Not Meaningful